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ABSTRACT
Recently, we synthesized pyrimidine derivatives
of the 2’-O,4’-C-methylenoxymethylene-bridged
nucleic-acid (2’,4’-BNA
COC) monomer, the sugar
conformation of which is restricted in N-type con-
formation by a seven-membered bridged structure.
Oligonucleotides (BNA
COC) containing this mono-
mer show high affinity with complementary
single-stranded RNA and significant resistance to
nuclease degradation. Here, BNA
COC consisting of
2’,4’-BNA
COC monomers bearing all four bases,
namely thymine, 5-methylcytosine, adenine and
guanine was efficiently synthesized and properties
of duplexes containing the 2’,4’-BNA
COC monomers
were investigated by UV melting experiments and
circular dichroism (CD) spectroscopy. The UV melt-
ing curve analyses showed that the BNA
COC/
BNA
COC duplex possessed excellent thermal stabil-
ity and that the BNA
COC increased thermal stability
with a complementary RNA strand. On the other
hand, BNA
COC/DNA heteroduplexes showed almost
the same thermal stability as RNA/DNA hetero-
duplexes. Furthermore, mismatched sequence
studies showed that BNA
COC generally improved
the sequence selectivity with Watson–Crick base-
pairing compared to the corresponding natural
DNA and RNA. A CD spectroscopic analysis
indicated that the BNA
COC formed duplexes with
complementary DNA and RNA in a manner similar
to natural RNA.
INTRODUCTION
Antisense oligonucleotides are now attracting interest for
their potential to be developed as a new class of drugs for
treatment of inveterate diseases such as cancer and viral
diseases. For practical application of antisense methodol-
ogy, it is essential to develop modiﬁed oligonucleotides,
which strongly interact with single-stranded RNA
(ssRNA) in a sequence-speciﬁc manner (1–3). The sugar
moiety of natural nucleosides and single-stranded oligo-
nucleotides exists in an individual equilibrium mixture
between S-type and N-type conformations. However, it
is well known that the B-form DNA duplex possesses
the S-type sugar conformation, and that a range of
N-type sugar conformation (pseudorotation phase angle,
0 P 368) are adapted to the A-form RNA duplex struc-
ture (Figure 1) (4–6). Therefore, modiﬁed oligonucleo-
tides, which have sugar moiety restricted to the S-type
or N-type conformations in advance, are expected to
have high binding aﬃnity with complementary ssDNA
or ssRNA respectively. We have so far developed various
kinds of bridged nucleic acids (BNAs) (7–19), the sugar
conformation of which is restricted or locked by introduc-
tion of an additional bridged structure to the furanose
skeleton. It has been observed that 20,40-BNA (9,10)/
LNA [The 20,40-BNA was independently synthesized by
the group of Wengel et al. immediately after our ﬁrst
report (9), and it is called a locked nucleic acid (LNA).
See refs (3,20–22)] (Figure 2), which is a BNAs with its
sugar moiety ﬁxed to an N-type conformation by ﬁve-
membered ring, prominently hybridizes to ssRNA targets.
An X-ray crystallographic analysis of 20,40-BNA showed
that the maximum out-of-plane ( max) value was 578, and
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( max¼38.68 38) to natural A-form RNA duplex (4–6),
so the N-type nature of 20,40-BNA was emphasized due
to the restriction of the sugar moiety by the small ﬁve-
membered ring. Other nucleic-acid analogues with a dif-
ferent type of bridged structure between the 20- and
40-positions, which have six- and seven-membered ring,
have been reported (16–19,23–29). In one of these studies,
we described the synthesis and properties of 20-O,40-C-
aminomethylene BNA (20,40-BNA
NC) (Figure 2), and
showed that oligonucleotides containing 20,40-BNA
NC
have high hybridizing aﬃnity with RNA compliments
(16–19). X-ray crystallographic analysis revealed that the
P and  max values of 20,40-BNA
NC[NMe] were 238 and 498,
respectively (19). These values indicated that the confor-
mation of 20,40-BNA
NC[NMe] is restricted to the N-type
conformation as seen in natural A-form RNA duplex.
This suggested that the sugar conformation restricted by
the bridged structure between the 20- and 40-positions
approximated to the adapted sugar conformation of
the natural A-form RNA duplex because of increased
ring size. Recently, we designed 20,40-BNA
COC, bearing a
seven-membered bridged structure, and successfully
synthesized the 20,40-BNA
COC monomers having pyrimi-
dine nucleobases (Figure 2) (30). The oligonucleotides
containing these monomers show high aﬃnity with com-
plementary ssRNA. An X-ray crystallographic analysis of
20,40-BNA
COC bearing thymine showed that the P and
 max values were 178 and 388, respectively. This revealed
that the sugar conformation of 20,40-BNA
COC, which is
restricted by a large seven-membered ring, is identical
with the N-type sugar puckering ﬁt to canonical A-form
RNA duplex, and that 20,40-BNA
COC has the closest sugar
conformation among nucleic-acid analogues with a diﬀer-
ent type of bridged structure between the 20- and
40-positions.
It is of great interest to synthesize 20,40-BNA
COC bearing
a purine nucleobase for potential use in a wide variety
of applications and to investigate the conformations of
oligonucleotides containing 20,40-BNA
COC. Moreover,
conformational analysis of duplex, which is formed
from fully modiﬁed oligonucleotides consisted of
20,40-BNA
COC, is very fascinating. In general, a purine
glycosidic linkage is more acid-labile than a pyrimidine
glycosidic linkage (31). Therefore, it is readily expected
that the acidic conditions used for the synthesis of
20,40-BNA
COC with a pyrimidine nucleobase are not suit-
able for the purine congener (Scheme 1). Here, we report
the synthesis of 20,40-BNA
COC monomers having a purine
nucleobase via formation of a COC linkage under mild
conditions, and we describe the properties of the corre-
sponding oligonucleotide derivatives.
MATERIALS AND METHODS
General aspectsand instrumentation
All reactions were performed under an atmosphere of
nitrogen. Unless otherwise mentioned, all chemicals
from commercial sources were used without further
puriﬁcation. Acetonitrile (MeCN), dichloromethane
(CH2Cl2), dichloroethane (DCE), triethylamine and
pyridine were distilled from CaH2. Tetrahydrofuran
(THF) was distilled from CaH2 followed by LiAlH4 just
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Figure 1. Sugar conformations and helix structures of double-stranded nucleic acids.
Figure 2. Structures of 20,40-BNA/LNA, ENA, 20,40-BNA
NC, PrNA and 20,40-BNA
COC monomers.
1226 Nucleic Acids Research, 2009, Vol. 37,No. 4before use. All melting points were measured with a
Yanagimoto micro melting point apparatus and are
uncorrected.
1H NMR (270 or 300MHz),
13C NMR
(67.8 or 75.5MHz) and
31P NMR (202.4MHz) spectra
were recorded on JEOL EX-270, JEOL-AL-300 and
JEOL GX-500 spectrometers, respectively. Chemical
shifts are reported in parts per million downﬁeld from
tetramethylsilane or deuterated solvent as internal stan-
dard for
1H and
13C spectra, and 85% H3PO4 as external
standard for
31P spectra. IR spectra were recorded on a
JASCO FT/IR-200 spectrometer. Optical rotations were
recorded on a JASCO DIP-370 instrument. Mass spectra
were measured on JEOL JMS-600 or JMS-700 mass
spectrometers. Column chromatography was carried out
using Fuji Silysia PSQ100B or FL-100D. Matrix-assisted
laser desorption ionization-time of ﬂight (MALDI-TOF)
mass spectra were recorded on Bruker Daltonics
Autoﬂex II TOF/TOF instruments.
4’-C-Acetoxymethyl-2’-O-acetyl-6-N-benzoyl-
3’-O-benzyl-5’-O-tert-butyldiphenylsilyladenosine (5)
Trimethylsilyl chloride (TMSCl) (0.5ml) was added to a
suspension of N
6-benzoyladenine (2.17g, 9.07mmol) in
anhydrous hexamethyldisilazane (HMDS) (35ml) at
room temperature and the mixture was reﬂuxed for 24h.
After the resulting clear solution was evaporated under
reduced pressure, to the residue a solution of compound
4 (30) (4.80g, 7.56mmol) in anhydrous DCE (25ml) and
trimethylsilyl triﬂuorimethanesulfonate (TMSOTf)
(0.14ml, 0.756mmol) were added and the mixture was
reﬂuxed for 11h. After addition of saturated aqueous
NaHCO3 solution at 08C, the mixture was extracted with
AcOEt. The organic extracts were washed with water and
brine, dried over Na2SO4, and concentrated under reduced
pressure. The residue was puriﬁed by silica gel column
chromatography [hexane/AcOEt (3:4!1:2, v/v)] to give
compound 5 (4.68g, 76%). White powder; m.p. 71–738C.
[a]D
26 6.80 (c 1.03, CHCl3). IR  max (KBr): 3065, 2939,
2862, 1744, 1703, 1607, 1458, 1368, 1235, 1106cm
 1.
1H
NMR (CDCl3): d 1.06 (9H, s), 1.97 (3H, s), 2.05 (3H, s),
3.81(1H, d, J¼11Hz), 3.96 (1H, d, J¼11Hz), 4.30 (1H, d,
J¼12Hz), 4.66 (1H, d, J¼12Hz), 4.62 (2H, s), 4.91
(1H, d, J¼6Hz), 6.08 (1H, t, J¼6Hz), 6.25 (1H, d,
J¼5Hz), 7.31–7.66 (18H, m), 8.01 (2H, d, J¼7Hz),
8.09 (1H, s), 8.59 (1H, s), 9.04 (1H, brs).
13C NMR
(CDCl3): d 19.3, 20.7, 20.9, 26.9, 26.9, 26.9, 62.7, 64.0,
74.1, 74.7, 78.1, 86.6, 87.0, 123.4, 127.7, 127.7, 127.7,
127.7, 127.7, 127.7, 127.8, 127.8, 128.0, 128.4, 128.4,
128.7, 128.7, 129.8, 129.8, 132.3, 132.4, 132.6, 133.4,
135.4, 135.4, 135.4, 135.4, 136.9, 142.1, 149.4, 151.2,
152.4, 164.4, 169.7, 170.4. Mass (FAB): m/z 814 (MH
þ).
Anal. Calcd for C45H47N5O8Si 1/2H2O: C, 65.67; H, 5.88;
N, 8.51. Found: C, 65.44; H, 5.71; N, 8.42.
6-N-Benzoyl-3’-O-benzyl-5’-O-tert-
butyldiphenylsilyl-4’-C-(hydroxymethyl)adenosine (6)
K2CO3 (98mg, 0.712mmol) was added to a solution of
compound 5 (193mg, 0.237mmol) in MeOH (3.4ml) at
08C, and the mixture was stirred at the same temperature
for 1.5h. After neutralization with a 10% aqueous HCl
solution (0.26ml), the mixture was extracted with AcOEt.
The organic extracts were washed with water and brine,
dried over Na2SO4, and concentrated under reduced pres-
sure. The residue was puriﬁed by silica gel column chro-
matography [hexane/AcOEt (1:3, v/v)] to give compound
6 (170mg, 98%). White powder; m.p. 88–908C.
[a]D
26þ4.43 (c 1.43, CHCl3). IR  max (KBr): 3287, 3062,
2937, 2862, 1702, 1612, 1461, 1328, 1253, 1109cm
 1.
1H
NMR (CDCl3): d 1.00 (9H, s), 2.57 (1H, dd, J¼5, 7Hz),
3.71 (1H, d, J¼11Hz), 3.76 (1H, d, J¼11Hz), 3.86 (1H,
dd, J¼7, 12Hz), 4.02 (1H, dd, J¼5, 12Hz), 4.52 (1H, d,
J¼8Hz), 4.66 (1H, d, J¼6Hz), 4.68 (1H, d, J¼11Hz),
4.85 (1H, d, J¼11Hz), 4.90 (1H, m), 6.10 (1H, d,
J¼4Hz), 7.22–7.44 (11H, m), 7.50–7.65 (7H, m), 8.02
(2H, d, J¼7Hz), 8.08 (1H, s), 8.64 (1H, s), 8.99 (1H,
brs).
13C NMR (CDCl3): d 19.3, 26.9, 26.9, 26.9, 63.0,
65.8, 73.8, 74.2, 78.7, 89.3, 91.0, 123.1, 127.6, 127.6,
127.7, 127.7, 127.7, 128.0, 128.0, 128.2, 128.2, 128.5,
128.5, 128.7, 128.7, 129.8, 129.8, 132.2, 132.5, 132.7,
133.4, 135.3, 135.3, 135.4, 135.4, 137.0, 142.0, 149.4,
150.7, 152.3, 164.4. Mass (FAB): m/z 730 (MH
þ). Anal.
Calcd for C41H43N5O6Si 3/2H2O: C, 65.06; H, 6.13; N,
9.25. Found: C, 65.30; H, 5.86; N, 9.19.
4’-C-Acetoxymethyl-2’-O-acetyl-6-N-benzoyl-3’-O-
benzyl-6-N-benzyloxymethyl-5’-O-tert-
butyldiphenylsilyladenosine (8)
DBU (0.39ml, 2.58mmol) was added to a solution of
compound 5 (1.05g, 1.29mmol) in anhydrous DMF
(6.4ml) at 08C and the mixture was stirred for 10min.
Benzyloxymethyl chloride (BOMCl) (0.27ml, 1.93mmol)
was added to the reaction mixture at 08C and the mixture
was stirred at the same temperature for 1h. After addition
of water at 08C, the mixture was extracted with Et2O.
The organic extracts were washed with 0.5M aqueous
KHSO4 solution, water and brine, dried over MgSO4,
Scheme 1. Reagents and conditions: (a) p-TsOH H2O, (CH2O)n, DCE, reﬂux, 3h, 81%; (b) TBAF, THF, rt, 3h, 91%; (c) 20% Pd(OH)2-C,
cyclohexene, EtOH, reﬂux, 3h, 89%.
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puriﬁed by silica gel column chromatography [hexane/
AcOEt (2:1, v/v)] to give compound 8 (769mg, 64%).
White foam. [a]D
26 16.4 (c 1.23, CHCl3). IR  max
(KBr): 3064, 2939, 2863, 2251, 1962, 1894, 1745, 1680,
1581, 1456, 1366, 1227, 1105cm
 1.
1H NMR (CDCl3): d
1.04 (9H, s), 1.96 (3H, s), 2.03 (3H, s), 3.79 (1H, d,
J¼11Hz), 3.92 (1H, d, J¼11Hz), 4.28 (1H, d,
J¼12Hz), 4.62 (1H, d, J¼12Hz), 4.59 (2H, s), 4.76
(2H, s), 4.87 (1H, d, J¼6Hz), 5.87 (2H, s), 5.98 (1H, t,
J¼6Hz), 6.18 (1H, d, J¼5Hz), 7.14–7.46 (19H, m), 7.50
(2H, d, J¼7Hz), 7.60-7.64 (4H, m), 7.99 (1H, s), 8.38
(1H, s).
13C NMR (CDCl3): d 19.3, 20.7, 20.9, 26.9,
26.9, 26.9, 62.8, 63.9, 71.3, 74.0, 74.7, 76.7, 78.0, 86.5,
87.0, 127.1, 127.5, 127.5, 127.7, 127.7, 127.7, 127.8,
127.8, 127.8, 127.9, 127.9, 128.1, 128.1, 128.1, 128.1,
128.4, 128.4, 128.7, 128.7, 129.9, 129.9, 131.0, 132.3,
132.4, 135.3, 135.4, 135.4, 135.5, 135.5, 136.9, 137.6,
142.8, 151.9, 152.1, 153.2, 169.7, 170.4, 172.2. Mass
(FAB): m/z 934 (MH
þ). Anal. Calcd for
C53H55N5O9Si 1/3H2O: C, 67.71; H, 5.97; N, 7.45.
Found: C, 67.64; H, 5.88; N, 7.40.
6-N-Benzoyl-3’-O-benzyl-6-N-benzyloxymethyl-5’-O-tert-
butyldiphenylsilyl-4’-C-(hydroxymethyl)adenosine (9)
K2CO3 (1.61g, 11.6mmol) was added to a solution of
compound 8 (3.62g, 3.88mmol) in MeOH (80ml) at 08C
and the mixture was stirred for 50min. After neutraliza-
tion with a 10% aqueous HCl solution (4.3ml), the mix-
ture was extracted with AcOEt. The organic extracts were
washed with water and brine, dried over Na2SO4, and
concentrated under reduced pressure. The residue was
puriﬁed by silica gel column chromatography [hexane/
AcOEt (3:2 to 1:1, v/v)] to give compound 9 (3.21g,
97%). White powder; m.p. 54–578C. [a]D
26 1.94
(c 1.23, CHCl3). IR  max (KBr): 3326, 3064, 2940, 2864,
2247, 1962, 1894, 1820, 1677, 1581, 1458, 1281, 1210,
1070cm
 1.
1H NMR (CDCl3): d 0.99 (9H, s), 2.51 (1H,
dd, J¼5, 7Hz), 3.70 (2H, s), 3.80 (1H, dd, J¼7, 12Hz),
3.97 (1H, dd, J¼5, 12Hz), 4.47 (1H, d, J¼9Hz), 4.58
(1H, d, J¼6Hz), 4.63 (1H, d, J¼11Hz), 4.80 (1H, d,
J¼11Hz), 4.77 (1H, m), 4.78 (2H, s), 5.88 (2H, s), 6.04
(1H, d, J¼4Hz), 7.10-7.44 (19H, m), 7.48–7.56 (6H, m),
8.00 (1H, s), 8.43 (1H, s).
13C NMR (CDCl3): d 19.3, 26.9,
26.9, 26.9, 63.2, 65.7, 71.3, 73.9, 74.2, 76.7, 78.7, 89.1, 90.9,
127.1, 127.5, 127.5, 127.7, 127.7, 127.7, 127.7, 127.9, 127.9,
128.0, 128.0, 128.1, 128.1, 128.3, 128.3, 128.6, 128.6, 128.7,
128.7, 129.9, 129.9, 131.1, 132.2, 132.4, 135.3, 135.3, 135.3,
135.4, 135.4, 136.9, 137.6, 142.6, 151.6, 151.8, 153.2, 172.2.
Mass (FAB): m/z 850 (MH
þ). Anal. Calcd for
C49H51N5O7Si 3/4H2O: C, 68.15; H, 6.13; N, 8.11.
Found: C, 68.30; H, 6.06; N, 8.07.
6-N-Benzoyl-3’-O-benzyl-6-N-benzyloxymethyl-5’-O-tert-
butyldiphenylsilyl-2’-O,4’-C- (methylenoxymethylene)
adenosine(10)
N-bromosuccinimide (NBS) (312mg, 1.75mmol) was
added to a solution of compound 9 (373mg,
0.438mmol) in anhydrous dimethylsulfoxide (DMSO)
(5.5ml) at room temperature and the mixture was stirred
at 608C for 1.5h. After addition of saturated aqueous
NaHCO3 solution at 08C, the mixture was extracted
with AcOEt. The organic extracts were washed with
water and brine, dried over Na2SO4, and concentrated
under reduced pressure. The residue was puriﬁed by
silica gel column chromatography [hexane/AcOEt (3:1,
v/v)] to give compound 10 (281mg, 74%). White foam.
[a]D
27 3.97 (c 1.01, CHCl3). IR  max (KBr): 3064, 2955,
2865, 1679, 1580, 1456, 1362, 1281, 1209, 1176, 1117,
1074cm
 1.
1H NMR (CDCl3): d 0.97 (9H, s), 3.68
(1H, d, J¼12Hz), 3.81 (1H, d, J¼12Hz), 3.72 (1H, d,
J¼12Hz), 3.88 (1H, d, J¼12Hz), 4.62 (1H, d,
J¼11Hz), 4.81 (1H, d, J¼11Hz), 4.79 (2H, s), 4.83
(1H, d, J¼6Hz), 4.99 (1H, d, J¼6Hz), 5.25 (1H, d,
J¼6Hz), 5.40 (1H, d, J¼6Hz), 5.91 (2H, s), 6.42 (1H,
s), 7.10-7.42 (19H, m), 7.50 (2H, d, J¼7Hz), 7.54–7.59
(4H, m), 8.14 (1H, s), 8.50 (1H, s).
13C NMR (CDCl3): d
19.2, 26.8, 26.8, 26.8, 62.7, 71.3, 71.7, 72.8, 75.8, 76.0, 76.7,
89.0, 91.8, 96.0, 127.3, 127.5, 127.5, 127.6, 127.6, 127.7,
127.7, 127.8, 127.8, 127.9, 127.9, 127.9, 127.9, 128.1, 128.1,
128.4, 128.4, 128.7, 128.7, 129.8, 129.8, 130.9, 132.2, 132.3,
135.3, 135.3, 135.4, 135.4, 135.4, 136.8, 137.7, 142.6, 151.5,
151.9, 153.1, 172.2. Mass (FAB): m/z 862 (MH
þ). Anal.
Calcd for C50H51N5O7Si 1/10H2O: C, 69.52; H, 5.97; N,
8.11. Found: C, 69.29; H, 5.86; N, 7.96.
3’-O-Benzyl-6-N-benzyloxymethyl-5’-O-tert-
butyldiphenylsilyl-2’-O,4’-C-
(methylenoxymethylene)adenosine (11)
Twenty-eight percent aqueous NH3 (1.2ml) was added to
a solution of compound 10 (209mg, 0.242mmol) in THF
(2.4ml) at room temperature. The ﬂask was sealed and the
mixture was stirred at 508C for 48h. The mixture was
extracted with AcOEt. The organic extracts were washed
with water and brine, dried over Na2SO4, and concen-
trated under reduced pressure. The residue was puriﬁed
by silica gel column chromatography [hexane/AcOEt
(2:1, v/v)] to give compound 11 (186mg, quant.). White
foam. [a]D
27þ2.62 (c 1.33, CHCl3). IR  max (KBr): 3266,
3037, 2938, 2246, 1959, 1897, 1615, 1475, 1418, 1357,
1292, 1176, 1116cm
 1.
1H NMR (CDCl3): d 0.99 (9H,
s), 3.69 (1H, d, J¼11Hz), 3.73 (1H, d, J¼12Hz), 3.83
(1H, d, J¼11Hz), 3.90 (1H, d, J¼12Hz), 4.62 (1H, d,
J¼11Hz), 4.66 (2H, s), 4.82 (1H, d, J¼11Hz), 4.92 (1H,
d, J¼6Hz), 5.04 (1H, d, J¼6Hz), 5.27 (1H, d, J¼6Hz),
5.28 (2H, brd, J¼7Hz), 5.41 (1H, d, J¼6Hz), 6.43 (1H,
s), 6.52 (1H, brs), 7.21–7.43 (16H, m), 7.57–7.60 (4H, m),
8.03 (1H, s), 8.38 (1H, s).
13C NMR (CDCl3): d 19.2, 26.7,
26.7, 26.7, 62.9, 70.0, 71.6, 72.7, 75.9, 76.0, 88.7, 91.8, 95.9,
120.5, 127.5, 127.5, 127.6, 127.6, 127.6, 127.6, 127.7, 127.7,
127.8, 127.8, 128.0, 128.0, 128.2, 128.2, 128.4, 128.4, 129.7,
129.7, 132.2, 132.4, 135.3, 135.3, 135.4, 135.4, 136.9, 137.8,
139.5, 152.7, 154.3. Mass (FAB): m/z 758 (MH
þ). Anal.
Calcd for C43H47N5O6Si: C, 68.14; H, 6.25; N, 9.24.
Found: C, 68.11; H, 6.29; N, 9.10.
3’-O-Benzyl-6-N-benzyloxymethyl-2’-O,4’-C-
(methylenoxymethylene)adenosine (12)
Tetrabutylammonium ﬂuoride (TBAF) (1.0M solution in
THF, 0.19ml, 0.19mmol) was added to a solution of
1228 Nucleic Acids Research, 2009, Vol. 37,No. 4compound 11 (128mg, 0.169mmol) in THF (1.7ml) at
room temperature and the mixture was stirred at room
temperature for 3h. After addition of hexane/AcOEt
(1:1, v/v, 2.0ml) at room temperature, the mixture was
evaporated under reduced pressure to one-tenth of its
volume. The residue was puriﬁed by silica gel column
chromatography [hexane/AcOEt (2:5, v/v)] to give com-
pound 12 (80mg, 91%). White foam. [a]D
27 8.40 (c 1.17,
CHCl3). IR  max (KBr): 3286, 2919, 2245, 1959, 1616,
1484, 1358, 1293, 1213, 1176, 1116, 1056cm
 1.
1H NMR
(CDCl3): d 2.21 (1H, brs), 3.69 (1H, d, J¼12Hz), 3.82
(1H, d, J¼12Hz), 3.79 (2H, s), 4.52 (1H, d, J¼6Hz),
4.65 (2H, s), 4.70 (1H, d, J¼11Hz), 4.78 (1H, d,
J¼11Hz), 5.25 (1H, d, J¼6Hz), 5.26 (2H, brs), 5.26
(1H, d, J¼6Hz), 5.43 (1H, d, J¼6Hz), 6.35 (1H, s),
7.14 (1H, brs), 7.22–7.38 (10H, m), 7.86 (1H, s), 8.35
(1H, s).
13C NMR (CDCl3): d 61.1, 70.1, 71.7, 73.0,
74.9, 77.5, 89.7, 93.1, 96.0, 120.5, 127.6, 127.7, 127.7,
127.8, 127.8, 127.8, 128.0, 128.3, 128.3, 128.3, 128.3,
128.3, 136.9, 137.7, 139.5, 152.5, 154.5. Mass (FAB): m/z
520 (MH
þ). Anal. Calcd for C27H29N5O6 1/6H2O: C,
62.06; H, 5.66; N, 13.40. Found: C, 61.79; H, 5.63; N,
13.29.
2’-O,4’-C-(Methylenoxymethylene)adenosine (13)
Twenty percent Pd(OH)2-C (750mg) and ammonium for-
mate (3.00g, 47.43mmol) were added to a solution of
compound 12 (493mg, 0.949mmol) in EtOH/AcOH
(100:3, v/v, 24ml) at room temperature and the mixture
was reﬂuxed for 3.5h. The hot solution was ﬁltrated
through a Celite pad and Celite was washed with boiling
MeOH (200ml). After addition of SiO2 (3.0g) to the ﬁl-
trate, the mixture was concentrated under reduced pres-
sure. The residue was puriﬁed by silica gel column
chromatography [CHCl3/MeOH (15:1!12:1, v/v)] to
give compound 13 (162mg, 55%). Colorless crystals;
m.p. 255–2578C (MeOH). [a]D
23 26.8 (c 0.86, DMSO).
IR  max (KBr): 3132, 1683, 1611, 1477, 1418, 1330, 1175,
1119, 1080cm
 1.
1H NMR (DMSO-d6): d 3.53 (1H, dd,
J¼6, 12Hz), 3.61 (1H, dd, J¼6, 12Hz), 3.65 (1H, d,
J¼12Hz), 3.80 (1H, d, J¼12Hz), 4.41 (1H, d,
J¼6Hz), 4.85 (1H, t, J¼6Hz), 5.09 (1H, d, J¼6Hz),
5.30 (1H, d, J¼6Hz), 5.14 (1H, t, J¼6Hz), 6.09 (1H,
brd, J¼4Hz), 6.23 (1H, s), 7.27 (2H, s), 8.13 (1H, s),
8.32 (1H, s).
13C NMR (DMSO-d6): d 60.9, 68.9, 70.7,
78.7, 88.8, 90.0, 94.9, 119.2, 139.0, 148.5, 152.5, 156.0.
Mass (FAB): m/z 310 (MH
þ). Anal. Calcd for
C12H15N5O5: C, 46.60; H, 4.89; N, 22.64. Found: C,
46.39; H, 4.99; N, 22.38.
6-N-Benzoyl-2’-O,4’-C-(methylenoxymethylene)
adenosine (14)
Benzoyl chloride (0.016ml, 0.136mmol) was added to a
solution of compound 13 (8.4mg, 0.027mmol) in anhy-
drous pyridine (0.3ml) at room temperature and the mix-
ture was stirred at room temperature for 12h. After
addition of saturated aqueous NaHCO3 solution at 08C,
the mixture was extracted with AcOEt. The organic
extracts were washed with saturated aqueous NaHCO3
solution twice, followed by washes with water and brine,
then dried over Na2SO4, and concentrated under reduced
pressure. The residue was dissolved in MeOH/1,4-dioxane
(2:1, v/v, 0.81ml) and NaOMe (28% solution in MeOH,
0.052ml) was added. After stirring for 5min at room
temperature, the mixture was neutralized with DOWEX
50W-X2 and ﬁltrated. After addition of SiO2 (1.0g) to the
ﬁltrate, the mixture was concentrated under reduced pres-
sure. The residue was puriﬁed by silica gel column chro-
matography [CHCl3/MeOH (40:1!20:1, v/v)] to give
compound 14 (7.7mg, 68% over two steps). White
powder; m.p. 133–1368C. [a]D
24 17.7 (c 0.88, DMSO).
IR  max (KBr): 3289, 2924, 1692, 1610, 1517, 1457, 1400,
1255, 1176, 1110cm
 1.
1H NMR (DMSO-d6): d 3.55 (1H,
dd, J¼6, 12Hz), 3.63 (1H, dd, J¼6, 12Hz), 3.66 (1H, d,
J¼12Hz), 3.81 (1H, d, J¼12Hz), 4.55 (1H, d, J¼6Hz),
4.87 (1H, t, J¼6Hz), 5.12 (1H, d, J¼6Hz), 5.32 (1H, d,
J¼6Hz), 5.20 (1H, t, J¼6Hz), 6.19 (1H, brd, J¼5Hz),
6.36 (1H, s), 7.52–7.67 (3H, m), 8.04 (2H, d, J¼7Hz),
8.66 (1H, s), 8.74 (1H, s), 11.24 (1H, brs).
13C NMR
(DMSO-d6): d 60.6, 68.8, 70.6, 78.5, 89.1, 90.2, 95.0,
126.0, 128.5, 128.5, 128.5, 128.5, 132.4, 133.6, 142.5,
150.7, 151.3, 151.5, 165.7. Mass (FAB): m/z 414 (MH
þ).
High-resolution MS (FAB): Calcd for C19H20N5O6
(MH
þ): 414.1414. Found: 414.1397.
6-N-Benzoyl-5’-O-(4,4’-dimethoxytrityl)-2’-O,4’-C-
(methylenoxymethylene)adenosine (15)
Synthesis of compound 15 from compound 14 (path A). To
a suspension of AgOTf (622mg, 2.42mmol) in CH2Cl2
(2.0ml) was added dropwise DMTrCl (820mg,
2.42mmol) in CH2Cl2 (8.0ml) at room temperature, and
the mixture was stirred for 1h at room temperature. The
supernatant ﬂuid (2.5ml, 2.5 eq.) was added to a solution
of compound 14 (101mg, 0.244mmol) in CH2Cl2/pyridine
(1:1, v/v, 4.8ml) at room temperature and the mixture was
stirred for 1h. After addition of saturated aqueous
NaHCO3 solution at 08C, the mixture was extracted
with AcOEt. The organic extracts were washed with
water and brine, dried over Na2SO4, and concentrated
under reduced pressure. The residue was puriﬁed by
silica gel column chromatography [hexane/AcOEt (1:2,
v/v)] to give compound 15 (183mg, quant.). White
powder; m.p. 125–1278C. [a]D
24 27.4 (c 0.71, CHCl3).
IR  max (KBr): 3325, 3062, 2922, 2245, 2050, 1901, 1703,
1609, 1509, 1456, 1251, 1178, 1073cm
 1.
1H NMR
(CDCl3): d 3.37 (1H, d, J¼10Hz), 3.42 (1H, d,
J¼10Hz), 3.39 (1H, d, J¼9Hz), 3.77 (6H, s), 4.01 (1H,
d, J¼13Hz), 4.06 (1H, d, J¼13Hz), 4.92 (1H, d,
J¼6Hz), 4.99 (1H, dd, J¼6, 9Hz), 5.23 (1H, d,
J¼7Hz), 5.33 (1H, d, J¼7Hz), 6.39 (1H, s), 6.78 (2H,
d, J¼9Hz), 6.79 (2H, d, J¼9Hz), 7.19–7.27 (7H, m),
7.34–7.38 (2H, m), 7.48–7.64 (3H, m), 8.01 (2H, d,
J¼7Hz), 8.10 (1H, s), 8.74 (1H, s), 9.07 (1H, s).
13C
NMR (CDCl3): d 55.2, 55.2, 64.5, 72.8, 73.4, 78.9, 86.6,
88.6, 88.9, 93.5, 113.1, 113.1, 113.1, 113.1, 123.3, 126.9,
127.7, 127.7, 127.8, 127.8, 127.8, 127.8, 128.7, 128.7, 129.8,
129.8, 129.8, 129.8, 132.7, 133.4, 135.0, 135.1, 141.3, 143.9,
149.4, 150.5, 152.4, 158.4, 158.4, 164.5. Mass (FAB): m/z
716 (MH
þ). High-resolution MS (FAB): Calcd for
C40H38N5O8 (MH
þ): 716.2720. Found: 716.2716.
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(path B). To a suspension of AgOTf (1.06g, 4.13mmol)
in CH2Cl2 (3.0ml) was added dropwise DMTrCl (1.40g,
4.13mmol) in CH2Cl2 (7.0ml) at room temperature and
the mixture was stirred for 1h. The supernatant ﬂuid
(3.0ml, 3.0 eq.) was added to a solution of compound
13 (128mg, 0.413mmol) in CH2Cl2/pyridine (1:2, v/v,
8.4ml) at room temperature and the mixture was stirred
for 1.5h. Benzoyl chloride (0.24ml, 2.07mmol) was added
to the mixture at room temperature and the mixture was
stirred for 24h. After addition of saturated aqueous
NaHCO3 solution at 08C, the mixture was extracted
with AcOEt. The organic extracts were washed with satu-
rated aqueous NaHCO3 solution twice, followed by
washes with water and brine, then dried over Na2SO4,
and concentrated under reduced pressure. The residue
was dissolved in THF (5.6ml) and 1M aqueous LiOH
(2.8ml, 2.8mmol) was added. After stirring for 5h at
room temperature, the mixture was extracted with
AcOEt. The organic extracts were washed with saturated
aqueous NaHCO3 solution twice, followed by washes with
water and brine, then dried over Na2SO4, and concen-
trated under reduced pressure. The residue was puriﬁed
by silica gel column chromatography [hexane/AcOEt
(1:2, v/v)] to give compound 15 (272mg, 92% over two
steps).
6-N-Benzoyl-3’-O-[2-
-cyanoethoxy(diisopropylamino)phosphino]-5’-O-(4,4’-
-dimethoxytrityl)-2’-O,4’-C-(methylenoxymethylene)
adenosine(17)
To a solution of compound 15 (283mg, 0.396mmol)
in MeCN (3.0ml) were added 4,5-dicyanoimidazole
(0.25M in MeCN, 1.9ml, 0.48mmol) and (i-Pr2N)2
POCH2CH2CN (0.19ml, 0.59mmol) at room temperature
and the mixture was stirred at room temperature for
16h. After removal of the solvent under reduced pressure,
the residue was diluted with AcOEt, washed with
saturated aqueous NaHCO3 solution, water and brine,
dried over Na2SO4, and concentrated under reduced
pressure. The residue was puriﬁed by silica gel
column chromatography [hexane/AcOEt (2:3, v/v)]
followed by the precipitation from hexane/AcOEt to
give compound 17 (304mg, 84%). White powder; m.p.
99–1028C.
31P NMR (CDCl3): d 150.7, 151.2. MS
(FAB): m/z 916 (MH
þ). High-resolution MS (FAB):
Calcd for C49H55N7O9P (MH
þ): 916.3799. Found:
916.3808.
4’-C-Acetoxymethyl-2’-O-acetyl-3’-O-benzyl-5’-O-tert-
butyldiphenylsilyl-6-O-diphenylcarbamoyl-2-N-isobutyryl-
guanosine(18)
To a suspension of O
6-(diphenylcarbamoyl)-N
2-isobutyr-
ylguanine (121mg, 0.291mmol) in DCE (1.9ml) was
added N,O-bis(trimethylsily)acetamide (0.17ml,
0.678mmol) at room temperature, and the mixture was
stirred at 808C for 30min. After the resulting clear solu-
tion was evaporated under reduced pressure, to the residue
a solution of compound 4 (123mg, 0.194mmol) in anhy-
drous toluene (1.9ml) and TMSOTf (0.04ml, 0.233mmol)
were added and the mixture was stirred at 808C for 2h.
After addition of saturated aqueous NaHCO3 solution
at 08C, the mixture was extracted with AcOEt. The
organic extracts were washed with water and brine,
dried over Na2SO4, and concentrated under reduced pres-
sure. The residue was puriﬁed by silica gel column chro-
matography [hexane/AcOEt (2:1 to 3:2, v/v)] to
give compound 18 (161mg, 84%). White powder; m.p.
86–888C. [a]D
25þ15.1 (c 0.97 CHCl3). IR  max (KBr):
3327, 3063, 2961, 2866, 2463, 2251, 1959, 1744, 1588,
1500, 1453, 1408, 1227, 1106cm
 1.
1H NMR (CDCl3): d
1.01 (9H, s), 1.15 (3H, d, J¼7Hz), 1.19 (3H, d, J¼7Hz),
1.94 (3H, s), 2.06 (3H, s), 2.77 (1H, m), 3.85 (2H, s), 4.31
(1H, d, J¼12Hz), 4.66 (1H, d, J¼12Hz), 4.65 (1H, d,
J¼11Hz), 4.74 (1H, d, J¼11Hz), 5.23 (1H, d, J¼6Hz),
5.88 (1H, dd, J¼4, 6Hz), 6.09 (1H, d, J¼4Hz), 7.18–7.45
(21H, m), 7.54–7.61 (4H, m), 7.82 (1H, brs), 7.98 (1H, s).
13C NMR (CDCl3): d 19.3, 19.3, 19.3, 20.8, 20.9, 26.9,
26.9, 26.9, 36.0, 62.5, 64.9, 74.3, 74.6, 78.3, 87.0, 87.2,
121.3, 127.4, 127.4, 127.6, 127.6, 127.6, 127.6, 127.7,
127.7, 127.7, 127.7, 127.7, 128.2, 128.2, 128.2, 128.2,
129.0, 129.0, 129.0, 129.0, 129.7, 129.7, 132.5, 132.6,
135.4, 135.4, 135.4, 135.4, 137.7, 137.7, 141.6, 142.9,
150.1, 151.7, 154.0, 156.0, 169.7, 170.5, 174.3.
Mass (FAB): m/z 991 (MH
þ). Anal. Calcd for
C55H58N6O10Si 1/10H2O: C, 66.53; H, 5.91; N, 8.46.
Found: C, 66.26; H, 5.96; N, 8.43.
3’-O-Benzyl-5’-O-tert-butyldiphenylsilyl-6-O-
diphenylcarbamoyl-4’-C-hydroxymethyl-2-N-
isobutyrylguanosine (19)
A mixture of 18 (100mg, 0.10mmol) and K2CO3 (42mg,
0.30mmol) in MeOH (1.4ml) was stirred at 08C for
40min. After neutralization with a 10% aqueous HCl
solution (0.11ml), the mixture was extracted with
AcOEt. The organic extracts were washed with water
and brine, dried over Na2SO4, and concentrated under
reduced pressure. The residue was puriﬁed by silica
gel column chromatography [hexane/AcOEt (3:2 to 1:1,
v/v)] to give compound 19 (88mg, 96%). White powder;
m.p. 94–968C. [a]D
24þ58.0 (c 0.91, CHCl3). IR  max
(KBr): 3311, 3063, 2958, 2865, 2248, 1958, 1890, 1744,
1588, 1499, 1452, 1407, 1330, 1180cm
 1.
1H NMR
(CDCl3): d 0.91 (9H, s), 1.24 (3H, d, J¼7Hz), 1.25 (3H,
d, J¼7Hz), 2.57 (1H, m), 3.55 (1H, d, J¼11Hz), 3.67
(1H, d, J¼11Hz), 3.80 (1H, d, J¼12Hz), 3.96 (1H, d,
J¼12Hz), 4.66 (1H, d, J¼5Hz), 4.74 (1H, d, J¼12Hz),
5.16 (1H, d, J¼12Hz), 4.80 (1H, t, J¼5Hz), 6.02 (1H, d,
J¼5Hz), 7.18–7.49 (25H, m), 8.05 (1H, brs), 8.11 (1H, s).
13C NMR (CDCl3): d 19.2, 19.3, 19.4, 26.8, 26.8, 26.8,
36.9, 63.7, 66.1, 74.3, 76.2, 80.2, 89.6, 91.5, 121.2, 127.5,
127.5, 127.6, 127.6, 127.6, 127.6, 127.9, 127.9, 128.0, 128.0,
128.0, 128.5, 128.5, 128.5, 128.5, 129.1, 129.1, 129.1, 129.1,
129.7, 129.7, 132.3, 132.4, 135.3, 135.3, 135.3, 135.3, 137.8,
137.8, 141.5, 142.9, 150.1, 151.1, 153.3, 155.9, 174.4.
Mass (FAB): m/z 907 (MH
þ). Anal. Calcd for
C51H54N6O8Si H2O: C, 66.21; H, 6.10; N, 9.08. Found:
C, 66.15; H, 5.93; N, 9.04.
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bamoyl-2-N-isobutyryl-2’-O,4’-C-(methylenoxymethylene)-
guanosine (20)
To a solution of 19 (123mg, 0.136mmol) in anhydrous
DMSO (1.7ml) was added NBS (145mg, 0.816mmol) at
room temperature and the mixture was stirred at 608C for
40min. After addition of saturated aqueous NaHCO3
solution at 08C, the mixture was extracted with AcOEt.
The organic extracts were washed with water and brine,
dried over Na2SO4, and concentrated under reduced pres-
sure. The residue was puriﬁed by silica gel column chro-
matography [hexane/AcOEt (3:1, v/v)] to give compound
20 (56mg, 45%). White powder; m.p. 97–998C.
[a]D
23þ39.1 (c 0.94, CHCl3). IR  max (KBr): 3313, 3062,
2962, 2865, 2246, 1958, 1890, 1745, 1588, 1500, 1451,
1405, 1328, 1176, 1116, 1068cm
 1.
1H NMR (CDCl3): d
0.97 (9H, s), 1.11 (3H, d, J¼7Hz), 1.17 (3H, d, J¼7Hz),
2.69 (1H, m), 3.80 (1H, d, J¼12Hz), 4.12 (1H, d,
J¼12Hz), 3.93 (2H, s), 4.79 (1H, d, J¼6Hz), 4.82 (2H,
s), 5.23 (1H, d, J¼6Hz), 5.47 (1H, d, J¼6Hz), 5.41 (1H,
d, J¼6Hz), 6.32 (1H, s), 7.05–7.10 (2H, m), 7.20–7.59
(23H, m), 7.84 (1H, brs), 8.07 (1H, s).
13C NMR
(CDCl3): d 19.2, 19.2, 19.3, 26.8, 26.8, 26.8, 36.2, 63.9,
71.6, 72.8, 76.4, 77.1, 89.1, 92.3, 96.0, 121.8, 127.2,
127.2, 127.5, 127.5, 127.5, 127.5, 127.7, 127.7, 127.7,
127.7, 127.7, 128.3, 128.3, 128.3, 128.3, 129.1, 129.1,
129.1, 129.1, 129.5, 129.6, 132.4, 132.8, 135.3, 135.3,
135.5, 135.5, 137.8, 137.8, 141.6, 143.3, 150.2, 151.3,
153.5, 155.9, 174.0. Mass (FAB): m/z 919 (MH
þ). Anal.
Calcd for C52H54N6O8Si 3/4H2O: C, 66.97; H, 6.00; N,
9.01. Found: C, 66.92; H, 5.91; N, 8.94.
3’-O-Benzyl-2-N-isobutyryl-2’-O,4’-C-(methyleno-
xymethylene)guanosine (21)
To a solution of 20 (801mg, 0.871mmol) in anhydrous
DMSO (7.2ml) was added NaNO2 (1.20g, 17.42mmol)
at room temperature and the mixture was stirred at
708C for 19h. After addition of saturated aqueous
NaHCO3 solution at 08C, the mixture was extracted
with AcOEt. The organic extracts were washed with
water and brine, dried over Na2SO4, and concentrated
under reduced pressure. The residue was dissolved in
THF (8.7ml) and TBAF (1.0M in THF, 1.05ml,
1.05mmol) was added. After stirring for 15h at room
temperature, the solvent was removed under reduce pres-
sure. The residue was puriﬁed by silica gel column chro-
matography [hexane/AcOEt (1:2, v/v) and AcOEt/EtOH
(50:1, v/v)] to give compound 21 (264mg, 62% over two
steps). Pale brown powder; m.p. 144–1468C. [a]D
26 30.0
(c 1.04, CHCl3). IR  max (KBr): 3157, 2975, 2923, 2248,
1682, 1607, 1559, 1473, 1406, 1315, 1252, 1169, 1117,
1074cm
 1.
1H NMR (CDCl3): d 1.25 (6H, d, J¼5Hz),
2.72 (1H, m), 3.75 (1H, d, J¼12Hz), 3.97 (1H, d,
J¼12Hz), 3.83 (1H, d, J¼12Hz), 3.92 (1H, d,
J¼12Hz), 4.44 (1H, d, J¼5Hz), 4.62 (1H, d,
J¼11Hz), 4.72 (1H, d, J¼11Hz), 4.94 (1H, d,
J¼5Hz), 5.16 (1H, d, J¼6Hz), 5.36 (1H, d, J¼6Hz),
6.18 (1H, s), 7.24–7.33 (5H, m), 8.04 (1H, s), 9.92 (1H,
brs), 12.09 (1H, brs).
13C NMR (CDCl3): d 19.1, 19.1,
36.1, 61.1, 71.7, 72.4, 75.9, 89.4, 91.6, 96.0, 120.6, 127.2,
127.2, 127.7, 128.3, 128.3, 128.3, 137.2, 138.4, 146.9, 147.7,
154.9, 179.3. Mass (FAB): m/z 486 (MH
þ). High-resolu-
tion MS (FAB): Calcd for C23H28N5O7 (MH
þ): 486.1989.
Found: 486.1980.
2-N-Isobutyryl-2’-O,4’-C-(methylenoxymethylene)
guanosine(22)
Twenty percent of Pd(OH)2-C (170mg) was added to a
solution of compound 21 (171mg, 0.351mmol) in
MeOH (7.0ml) at room temperature and the mixture
was stirred under an H2 atmosphere for 40h. After ﬁltra-
tion of the mixture, the ﬁltrate was concentrated under
reduced pressure. The residue was puriﬁed by silica
gel column chromatography [CHCl3/MeOH (15:1 to
10:1, v/v)] to give compound 22 (118mg, 85%). White
powder; m.p. 182–1848C. [a]D
24 12.2 (c 1.09, MeOH).
IR  max (KBr): 3239, 2978, 2932, 1681, 1606, 1566, 1473,
1405, 1316, 1253, 1181, 1111cm
 1.
1H NMR (CD3OD): d
1.22 (6H, d, J¼7Hz), 2.71 (1H, sept, J¼7Hz), 3.67 (1H,
d, J¼12Hz), 3.74 (1H, d, J¼12Hz), 3.75 (2H, s), 4.39
(1H, d, J¼6Hz), 4.73 (1H, d, J¼6Hz), 5.07 (1H, d,
J¼7Hz), 5.35 (1H, d, J¼7Hz), 6.23 (1H, s), 8.44 (1H,
brs).
13C NMR (DMSO-d6): d 19.1, 19.1, 34.9, 60.2, 68.3,
70.6, 79.0, 89.0, 89.3, 94.9, 120.2, 136.7, 147.8, 148.2,
154.8, 180.2. Mass (FAB): m/z 396 (MH
þ). High-resolu-
tion MS (FAB): Calcd for C16H22N5O7 (MH
þ): 396.1519.
Found: 396.1530.
5’-O-(4,4’-Dimethoxytrityl)-2-N-isobutyryl-2’-O,4’-C-
(methylenoxymethylene)guanosine (23)
To a solution of 22 (265mg, 0.670mmol) in anhydrous
pyridine (5.2ml) was added DMTrCl (454mg,
1.340mmol) at room temperature and the mixture was
stirred for 9h. After addition of saturated aqueous
NaHCO3 solution at 08C, the mixture was extracted
with AcOEt. The organic extracts were washed with
water and brine, dried over Na2SO4, and concentrated
under reduced pressure. The residue was puriﬁed by
silica gel column chromatography [CHCl3/MeOH (50:1
to 20:1, v/v)] to give compound 23 (442mg, 95%).
White powder; m.p. 173–1758C. [a]D
24þ24.4 (c 0.97,
CHCl3). IR  max (KBr): 3146, 2973, 2250, 2051, 1899,
1680, 1605, 1560, 1507, 1407, 1305, 1250, 1179, 1115,
1072, 1033cm
 1.
1H NMR (CDCl3): d 1.23 (3H, d,
J¼7Hz), 1.27 (3H, d, J¼7Hz), 2.75 (1H, sept,
J¼7Hz), 3.37 (1H, d, J¼10Hz), 3.56 (1H, d,
J¼10Hz), 3.70 (6H, s), 3.90 (1H, d, J¼13Hz), 4.19
(1H, d, J¼13Hz), 4.57 (1H, d, J¼5Hz), 5.10 (1H, brd,
J¼5Hz), 5.14 (1H, brs), 5.17 (1H, d, J¼7Hz), 5.37 (1H,
d, J¼7Hz), 6.19 (1H, s), 6.70 (4H, d, J¼9Hz), 7.11–7.18
(3H, m), 7.24 (4H, d, J¼9Hz), 7.32–7.36 (2H, m), 7.67
(1H, s), 9.58 (1H, brs), 12.34 (1H, brs).
13C NMR
(CDCl3): d 19.0, 19.1, 36.3, 55.1, 55.1, 64.6, 71.6, 72.5,
79.0, 86.2, 89.1, 91.3, 95.2, 112.8, 112.8, 112.8, 112.8,
121.1, 126.7, 127.5, 127.5, 128.1, 128.1, 129.9, 129.9,
129.9, 129.9, 135.4, 135.5, 138.8, 144.1, 147.7, 147.7,
155.5, 158.2, 158.2, 180.1. Mass (FAB): m/z 698 (MH
þ).
High-resolution MS (FAB): Calcd for C37H40N5O9
(MH
þ): 698.2826. Found: 698.2813.
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(4,4’-dimethoxytrityl)-2-N-isobutyryl-
2’-O,4’-C-(methylenoxymethylene)guanosine (24)
To a solution of 23 (440mg, 0.630mmol) in MeCN/THF
(1:1, v/v, 5.0ml) were added 4,5-dicyanoimidazole (0.25M
in MeCN, 3.0ml, 0.75mmol) and (i-Pr2N)2
POCH2CH2CN (0.30ml, 0.945mmol) at room tempera-
ture and the mixture was stirred for 19h. Then, 4,5-
-dicyanoimidazole (0.25M in MeCN, 2.6ml, 0.65mmol)
and (i-Pr2N)2POCH2CH2CN (0.30ml, 0.945mmol) were
added, and the mixture was further stirred at room tem-
perature for 6h. After removal of the solvent under
reduced pressure, the residue was diluted with AcOEt,
washed with saturated aqueous NaHCO3 solution, water
and brine, dried over Na2SO4, and concentrated under
reduced pressure. The residue was puriﬁed by silica gel
column chromatography [hexane/AcOEt (2:3, v/v)] fol-
lowed by precipitation from hexane/AcOEt to give com-
pound 24 (360mg, 64%). White powder; m.p. 124–1278C.
31P NMR (CDCl3): d 150.5, 150.6. MS (FAB): m/z 898
(MH
þ). High-resolution MS (FAB): Calcd for
C46H57N7O10P (MH
þ): 898.3905. Found: 898.3887.
Synthesis of BNA
COC 27and 30
Syntheses of 20,40-BNA
COC-modiﬁed oligonucleotides
(BNA
COC) 27 and 30 were performed at a 0.2mmol scale
on an automated DNA synthesizer (Applied Biosystems
Expedite
TM 8909) using the standard phosphoramidite
protocol except that the coupling time was increased
from the standard 1.5–20min. As an activator,
5-ethylthio-1H-tetrazole was used for every coupling
step. Oligonucleotide synthesis was performed on
DMTr-OFF mode. Cleavage from the universal CPG
support was accomplished by using a 2M ammonia meth-
anol solution at room temperature for 1.5h and removal
of the protecting groups was accomplished by using a 28%
ammonia solution at 558C for 15h. The obtained crude
oligonucleotides were puriﬁed with Sephadex
TM G-25
(Amersham Biosciences, NAP
TM 10 Column) followed
by reversed-phase HPLC (Waters XTerra MS C18
2.5mm, 10 50mm) [buﬀer A, 0.1M TEAA; buﬀer B,
0.1M TEAA/MeCN¼1:1, B 12% to 24%/30min, linear
gradient; ﬂow rate, 3.0ml/min]. The composition of the
oligonucleotides was conﬁrmed by MALDI-TOF-MS
analysis. MALDI-TOF-MS data ([M–H]
–) for oligonu-
cleotides 27 and 30: For 27, found 4354.19 (calcd
4354.71); for 30, found 4391.12 (calcd 4391.80).
UV melting experiments (Tm measurements)
UV melting experiments were carried out on a
SHIMADZU UV-1650PC spectrometer equipped with
Tm analysis accessory quartz cuvettes of 1cm optical
path length. The UV melting proﬁles were recorded in
10mM sodium phosphate buﬀer (pH 7.2) containing
100mM NaCl at scan rate of 0.58C/min with detection
at 260nm. The ﬁnal concentration of each oligonucleotide
was 4mM. The melting temperatures were obtained as the
maxima of the ﬁrst derivative of the melting curves.
CD spectroscopy
CD spectra were measured with a JASCO J-720W spectro-
photometer. Spectra were recorded at 128C in a quartz
cuvette of 0.1cm optical path length. The samples were
prepared in the same manner as described for the UV
melting experiments. The molar ellipticity was calculated
from the equation [ ] ¼  /cl, where   is the relative inten-
sity, c is the sample concentration, and l is the cell path
length in centimeters.
X-ray crystallographic data
Crystallographic data (excluding structure factors) of 13
has been deposited at the Cambridge Crystallographic
Data Center as supplementary publication no. CCDC
634527. Copy of the data can be obtained, free of
charge via www.ccdc.cam.ac.uk/cgi-bin/catreq.cgi (or
from the Cambridge Crystallographic Data Center, 12
Union Road, Cambridge CB2 1EZ, UK; fax: þ44 1223
336033; or email: deposit@ccdc.cam.ac.uk).
RESULTS
Synthesis of2’,4’-BNA
COC-A
As shown in Scheme 2, the synthesis of the protected
20,40-BNA
COC-A
Bz (7), bearing a seven-membered bridged
structure, from 4 (30) was performed. According to
Vorbru ¨ ggen’s procedure (32,33), triacetate 4 was coupled
with N
6-benzoyladenine to give 5. Two acetyl groups of 5
were removed to give diol 6 sequentially. At ﬁrst, diol 6
was treated with paraformaldehyde under acidic condi-
tions; the same reaction conditions for the synthesis of
the pyrimidine congener (Scheme 1) (30). However, the
methyleneacetal formation did not proceed, while cleavage
of the glycosidic linkage was predominantly observed.
Then, several reaction conditions were attempted for
formation of the methylenoxymethylene (COC) linkage
(Table 1). Basic reaction conditions were also employed;
however, the desired product 7 was not obtained at all
(Table 1, Run 2 and 3). At last, we found that the reaction
of diol 6 with NBS in DMSO (34) slightly proceeded to
give a trace amount of the target compound 7 bearing a
seven-membered bridged structure (Table 1, Run 4). The
methyleneacetal formation using NBS in DMSO was dra-
matically improved by protection with the benzyloxy-
methyl (BOM) group of the N
6-amide moiety, which
might cause many side reactions, to give the desired com-
pound 10 bearing a seven-membered bridged structure in
74% yield as shown in Scheme 3. Because all our attempts
for O
30
-debenzylation of 20,40-BNA
COC-adenine
(20,40-BNA
COC-A) in the presence of the N
6-benzoyl
group failed, we alternatively attempted to remove the
N
6-benzoyl group with 28% ammonia aqueous solution
to aﬀord 11. The tert-butyldiphenylsilyl (TBDPS) group
was removed by treatment with TBAF to give 12.
Hydrogenation of 12 with palladium hydroxide on
carbon and ammonium formate resulted in removal of
both benzyl and BOM groups to ﬁnally aﬀord the desired
20,40-BNA
COC-A monomer 13. As shown in Scheme 4,
after perbenzoylation of 13, the obtained compound was
1232 Nucleic Acids Research, 2009, Vol. 37,No. 4treated with sodium methoxide to give diol 14. Reaction of
a primary hydroxyl group in 14 with 4,40-dimethoxytrityl
triﬂuolomethanesulfonate (35) gave 15 in 68% yield from
13 (path A). We attempted another synthetic route to
improve the yield of 15. We found that reaction of
20,40-BNA
COC-A monomer 13 with 4,40-dimethoxytrityl
triﬂuolomethanesulfonate followed by treatment with
benzoyl chloride by a one-pot operation gave 16.
Selective removal of both the O
30
-benzoyl group and one
of the N
6-benzoyl groups gave 15 in 92% yield from 13
(path B). At last, phosphitylation of 15 led to the corre-
sponding amidite 17.
Synthesis of2’,4’-BNA
COC-G
As shown in Scheme 5, an amidite 24 was synthesized by
using a common intermediate 4 as the starting material.
To circumvent the formation of an N
7/N
9-diastereo-mix-
ture during nucleosidation of 4, we chose O
6-(diphenylcar-
bamoyl)-N
2-isobutyrylguanine as the base moiety (36) to
give 18 in 84% yield. After removal of the acetyl groups of
18, the bridge structure formation was accomplished by
the same reaction conditions as for the synthesis of the
adenine congener to aﬀord 20 in a moderate yield. The
O
6-diphenylcarbamoyl group was removed by treatment
with sodium nitrite (37) and subsequent desilylation by
TBAF leading to 21. Hydrogenolysis of 21 with palladium
hydroxide on carbon aﬀorded the desired 20,40-BNA
COC-
G
i-Bu monomer 22. Finally, dimethoxytritylation of 22
with 4,40-dimethoxytrityl chloride followed by phosphity-
lation gave the phosphoroamidite 24.
Structure of 2’,4’-BNA
COC-A and2’,4’-BNA
COC -G
The structural features of 20,40-BNA
COC-A monomer 13
were well conﬁrmed by
1H NMR measurement and X-ray
crystallography (Figure 3, Table 4, and also see experi-
mental sections). No scalar coupling between H10 and
H20 in the
1H NMR spectra of 13 and 22 strongly sug-
gested the North-type (N-type) sugar puckers, as observed
in a series of 20,40-BNA (LNA). The crystal structure of
20,40-BNA
COC-A (13) revealed the pseudorotation phase
angle P (328) supporting its N-type sugar pucker and
COC linkage conﬁguration surrounded the O30 atom.
Moreover, the  max and d values of 13 were 388 and 788,
respectively. These values are in good agreement with the
parameters of the C30-endo structure which is the typical
N-type seen in the A-form RNA duplex (4–6).
BNA
COC oligonucleotide synthesis
20,40-BNA
COC phosphoramidites were incorporated into
oligonucleotides by conventional phosphoramidite chem-
istry on an automated DNA synthesizer. The coupling
eﬃciency of 20,40-BNA
COC phosphoramidites was
decreased by using 4,5-dicyanoimidazole as an activator
due to steric hindrance of the seven-membered ring struc-
ture with a methylenoxymethylene linkage. After several
trials, we found that the coupling eﬃciency was remark-
ably improved (over 95% yield) when the coupling time
was prolonged to 20min from 90s for 20,40-BNA
COC
phosphoramidites and 5-ethylthio-1H-tetrazole was used
as the activator [In the case of PrNA which also has a
seven-membered ring structure, the coupling eﬃciency
9 steps O
OAc OBn
OAc
TBDPSO
AcO
O
O BnO
TBDPSO
O
O
OAc OBn
TBDPSO
AcO
N
N N
N
NHBz
O
OH OBn
TBDPSO
HO
N
N N
N
NHBz
N
N N
N
NHBz
O
OH
OH
OH
HO
OH
D-Glucose
a
c b
45
67
Scheme 2. Reagents and conditions: (a) silylated N
6-benzoyladenine, TMSOTf, DCE, reﬂux, 11h, 76%; (b)K 2CO3, MeOH, 08C, 1.5h, 98%;
(c) p-TsOH H2O, (CH2O)n, DCE, reﬂux.
Table 1. Attempt at cyclization of compound 6
O
O BnO
TBDPSO
O
O
OH OBn
TBDPSO
HO
N
N N
N
NHBz
N
N N
N
NHBz
Conditions
67
Run Reagents Solvent Temperature Result
1 (CH2O)n, p-TsOH DCE Reﬂux Complex mixture
2C H 2I2, t-BuOK DMF 608C Complex mixture
3C H 2I2, NaHMDS THF 608C Complex mixture
4 NBS DMSO 608C Trace of 7
Nucleic Acids Research,2009, Vol.37, No. 4 1233was not good ( 50–60%) even with the use of 5-ethylthio-
1H-tetrazole. See ref. (25)].
Duplexformation abilities of fully modifiedBNA
COC
oligonucleotides withDNA and RNA
The duplex forming abilities of fully 20,40-BNA
COC-mod-
iﬁed oligonucleotides (BNA
COC) containing all four bases
(thymine, 5-methylcytosine, adenine and guanine) were
examined by means of UV melting experiments. Base pair-
ing experiments of BNA
COC 27 and 30 were carried out
with complementary DNA, RNA and BNA
COC. The
melting temperatures (Tm) for the duplexes are depicted
in Table 2. In its own series, the BNA
COC duplex showed
an extremely high Tm value compared with the corre-
sponding DNA duplex (iTm>þ438C) and the RNA
Scheme 3. Reagents and conditions: (a) BOMCl, DBU, DMF, 08C, 1h, 64%; (b)K 2CO3, MeOH, 08C, 50min, 97%; (c) NBS, DMSO, 608C, 1.5h,
74%; (d) 28% NH3aq, THF, 508C, 48h, quant.; (e) TBAF, THF, rt, 3h, 91%; (f) 20% Pd(OH)2-C, HCOONH4, EtOH-AcOH, reﬂux, 3.5h, 55%.
a O
O HO
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O
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Scheme 4. Reagents and conditions: (a)( 1) BzCl, pyridine, rt, 12h, (2) NaOMe, MeOH-1,4-dioxane, rt, 15min, 68% over two steps; (b) DMTrOTf,
pyridine-CH2Cl2, rt, 1h, quant.; (c) DMTrOTf then BzCl, pyridine-CH2Cl2, rt, 21.5h; (d) LiOH H2O, THF-H2O, rt, 5h, 92% over two steps;
(e)( i-Pr2N)2POCH2CH2CN, DCI, MeCN, rt, 16h, 84%.
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BNA
COC constituted more stable pairing systems for 30/
26 and 27/29 than the RNA/RNA duplex (iTm of þ98C
and þ278C, respectively) and the DNA/RNA heterodu-
plex (iTm of þ308C each). On the other hand, BNA
COC/
DNA heteroduplexes 30/25 and 27/28 showed lower Tm
values compared with the DNA/DNA duplex (iTm of
 78C and  138C, respectively). BNA
COC 27 formed
stable duplex with complementary DNA 28 compared
with the corresponding RNA/DNA duplex (26/28), prob-
ably due to an eﬀect of 5-methyl group of 20,40-BNA
COC-T
in 27 [Probably, thymine in place of uracil nucleobase
should cause higher thermal stability of BNA
COC 27
with the DNA complement than that of natural RNA/
DNA duplex. See ref. (7) describing the eﬀect of displace-
ment of thymine with uracil in 20,40-BNA duplex.]
Remarkably, BNA
COC clearly distinguished complemen-
tary RNA from complementary DNA (iTm of þ398C for
27 and þ158C for 30, respectively), whereas natural
RNAs, 26 and 29, showed relatively poor discrimination
between complementary RNA and complementary DNA
(iTm of þ218C for 26 and þ38C for 29, respectively).
Mismatch discrimination of2’,4’-BNA
COC-modified
oligonucleotides
To analyze the base selectivity of BNA
COC, we investi-
gated the duplex stabilities between BNA
COC 27 and mis-
matched DNA or RNA complements. The melting
temperatures (Tm) of duplexes are shown in Table 3.
With the mismatched DNA complement, the Tm values
of natural DNA 25 decreased by  118Ct o 158C com-
pared to that of the fully-matched duplex, while both nat-
ural RNA 26 and BNA
COC 27 showed Tm values lower
than room temperature. In the case of duplexes with a
mismatched RNA complement, BNA
COC 27 recognized
one base mismatch (iTm¼ 68Ct o 218C) by a similar
manner to that observed in natural DNA 25
Scheme 5. Reagents and conditions: (a) silylated O
6-(diphenylcarbamoyl)-N
2-isobutyrylguanine, TMSOTf, toluene, 808C, 2h, 84%; (b)K 2CO3,
MeOH, 08C, 40min, 96%; (c) NBS, DMSO, 608C, 40min, 45%; (d)( 1) NaNO2, DMSO, 708C, 19h, (2) TBAF, THF, rt, 15h, 62% over
two steps; (e) 20% Pd(OH)2-C, H2, MeOH, rt, 40h, 85%; (f) DMTrCl, pyridine, rt, 9h, 95%; (g)( iPr2N)2POCH2CH2CN, DCI, MeCN-THF,
rt, 25h, 64%.
Figure 3. X-ray structure of 20,40-BNA
COC-A (13).
Nucleic Acids Research,2009, Vol.37, No. 4 1235(iTm¼ 58Ct o 168C). The diﬀerences in Tm values
between matched and mismatched duplexes were larger
than those observed for duplexes containing RNA 26
(iTm¼ 38Ct o 128C). As expected, the T G wobble
base pair was more stable than the other mismatched base
pairs in all cases investigated.
Analysisof thehelical structure of2’,4’-BNA
COC-modified
oligonucleotide
Circular dichroism spectroscopic analyses of BNA
COC-
hybridizing duplexes were performed to investigate the
structural preferences. CD spectra were recorded at 108C
for the BNA
COC duplex 27/30, the BNA
COC/DNA hetero-
duplexes 27/28 and 30/25, the BNA
COC/RNA heterodu-
plexes 27/29 and 30/26, as well as for the control DNA
duplex 25/28, the RNA duplex 26/29 and the DNA/RNA
duplexes 25/29 and 28/26 (Figure 4). The CD spectra of
BNA
COC duplex 27/30 and the BNA
COC/RNA heterodu-
plexes 27/29 and 30/26 were similar to that of the natural
RNA duplex. These spectra showed a large positive Cotton
band around 265nm and a large negative Cotton band at
210nm, indicating a typical A-form helix formation
(Figure 4A). In the case of the BNA
COC/DNA and the
RNA/DNA heteroduplexes, all spectra were very similar
to each other and the shoulder band around 280nm sug-
gested an intermediate between A- and B-form geometry.
This revealed that BNA
COC formed duplexes with comple-
mentary DNA in the same manner the natural RNA did.
Additionally, the CD proﬁle of the natural DNA duplex
belonged to no other types of duplexes in this study.
DISCUSSION
X-ray crystallography established the relationship
between the sugar conformation and the ring size of the
bridged structure between the 20- and 40-positions. The
values of selected torsion angles are summarized in
Table 4. In making a comparison between
20,40-BNA
COC-A monomer 13 and 20,40-BNA
COC-T mono-
mer 3, even though the pseudorotation phase angle P are
slightly diﬀerent from each other, they are in the range
preferred by the C30-endo conformation (08   P 368)
which is the typical N-type geometry ﬁt in a natural
A-form RNA duplex (4–6). From another point of view,
non-observed H10–H20 coupling in both
1H NMR spectra
suggested very similar N-type sugar puckering in the solu-
tion phase. These data indicate that the sugar conforma-
tion of 20,40-BNA
COC is ﬁxed to an N-type, but still
slightly ﬂexible. Molecular dynamics simulations sup-
ported its conformational features showing larger
P-amplitude of 20,40-BNA
COC than that of 20,40-BNA
(LNA) and 20,40-BNA
NC (Figure S1). Concerning the
 max values, which represent the maximum degree of the
sugar puckering mode (N/S-type), the sugar conformation
of 20,40-BNA
COC ( max 388) is very similar to that of a
natural A-form RNA duplex ( max 388) compared with
that of 20,40-BNA (LNA), ENA and 20,40-BNA
NC[NMe]
[ max 578 (7), 488 (23) and 498 (19), respectively]. These
results showed that the sugar conformation of
20,40-BNA
COC is closest to that of A-form RNA among
nucleic-acid analogues with a diﬀerent type of bridged
structure between the 20- and 40-positions.
NMR and molecular dynamics studies of the
20,40-BNA(LNA)-modiﬁed oligonucleotide (BNA) demon-
strated that the conformation of the complementary DNA
in BNA/DNA heteroduplexes is changed adaptively into a
suitable one to form A-form duplexes and results in larger
populations of N-type sugar puckers (38,39). On the other
hand, the 20,40-BNA
COC-modiﬁed oligonucleotide
(BNA
COC) duplex and the BNA
COC/RNA heteroduplexes
Table 2. Tm values (8C) of BNA
COC with complementary DNA, RNA and 20,40- BNA
COC oligonucleotides
Target strands
28 50-d(AGCAAAAAACGC)-30 29 50-r(AGCAAAAAACGC)-30 30 50-ag
mcaaaaaa
mcg
mc-30
25 50-d(GCGTTTTTTGCT)-30 52 48 45
26 50-r(GCGUUUUU1UGCU)-30 30 51 60
27 50-g
mcgttttttg
mc t-30 39 78 >95
The UV melting proﬁles were measured in 10mM sodium phosphate buﬀer (pH 7.2) containing 100mM NaCl at a scan rate of 0.58C/min at 260nm.
The concentration of the oligonucleotide used was 4mM for each strand. BNA
COC oligonucleotides are shown in small letters.
Table 3. Tm values (8C) of oligonucleotides 25–27 with their complementary DNA or RNA with or without a one base mismatch
Target sequence 50-d(AGCAAANAACGC)-30 Target sequence 50-r(AGCAAANAACGC)-30
N¼AT G C N ¼AU G C
25 50-d(GCGTTTTTTGCT)-30 52 38 ( 14) 41 ( 11) 37 ( 15) 48 33 ( 15) 43 ( 5) 32 ( 16)
26 50-r(GCGUUUUUUGCU)-30 30 <25 <25 <25 51 42 ( 9) 48 ( 3) 39 ( 12)
27 50-g
mcgttttttg
mc t-30 39 <25 <25 <25 78 62 ( 16) 72 ( 6) 57 ( 21)
Conditions: 10mM sodium phosphate buﬀer (pH 7.2) containing 100mM NaCl at a scan rate of 0.58C/min at 260nm. The concentration of the
oligonucleotide used was 4mM for each strand. The values in parentheses are diﬀerences in Tm values between mismatched and matched duplexes.
1236 Nucleic Acids Research, 2009, Vol. 37,No. 4showed the typical A-form features on the CD spectra,
while the BNA
COC/DNA heteroduplexes showed the
same aspect with the natural RNA/DNA duplex
(Figure 4). These diﬀerences between BNA and
BNA
COC probably correlate with the above-mentioned
conformational features of each monomer, that is to say,
the oligonucleotide bearing a ﬁxed N-type sugar confor-
mation and larger  max value than that of the typical
A-form duplex could force the complementary DNA to
take an N-type sugar conformation in the duplex.
Concerning the thermal stability, BNA
COC forms a very
stable duplex with complementary RNA, while it moder-
ately stabilizes the duplex with complementary DNA. On
the other hand, BNA formed extremely stable duplexes
with both complementary DNA and RNA (9,20–22), and
PrNA, which possesses an alternative –CH2CH2CH2–
group to –CH2OCH2–o f2 0,40-BNA
COC within the bridge
structure, leads to a decrease in duplex stabilities with both
complementary DNA and RNA (24). These diﬀerences in
hybridization properties would probably result from a bal-
ance between the entropic advantages derived from the
conformational restriction of the sugar moiety (10) and
the disadvantages caused by the additional bridge struc-
ture. BNA possesses a rigid N-type sugar restricted with
a small bridge to make a great entropic advantage over any
other disadvantages. In the case of BNA
COC, the entropic
advantage by the sugar restriction would be smaller
than that of BNA because of the large perturbation of
20,40-BNA
COC come from the larger bridge structure
compared with 20,40-BNA (LNA) (40; Supplementary
Figure S1). However, the hydrophilic bridge structure
of BNA
COC could somewhat positively inﬂuence the net-
work of hydration around the duplex. Consequently,
BNA
COC makes the duplex more thermally stable than
PrNA bearing a hydrophobic bridge structure.
BNA
COC has interesting features, such as high binding
aﬃnity towards the RNA complement and discrimination
between complementary RNA and DNA. Moreover, it
has been revealed that the modiﬁcation of 20,40-BNA
COC
leads to excellent nuclease resistance (30). These results
indicate a high potential for 20,40-BNA
COC in genome
technology. Further biological studies of 20,40-BNA
COC
are now in progress.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
FUNDING
This work was supported in part by a Grant-in-Aid for
Science Research from the Japan Society for the
Promotion of Science and the Molecular Imaging
Research Program from the Ministry of Education,
Culture, Sports, Science and Technology, Japan.
Funding for open access charge: Japan Society of
Promotion of Science.
Conﬂict of interest statement. None declared.
REFERENCES
1. Stein,C. A. and Krieg,A. M. (1998) Applied Antisense
Oligonucleotide Technology, Wiley-Liss, New York.
2. Schlingensiepen,R., Brysch,W. and Schlingensiepen,K. H. (1997)
Antisense—from Technology to Therapy, Black Sciences Ltd., Berlin.
Table 4. Selected parameters by X-ray analysis
d  max P
20,40-BNA
7) 668 578 178
ENA
24) 768 488 158
20,40-BNA
NC[NMe]
19) 758 498 238
20,40-BNA
coc-T (3)
30) 788 388 178
20,40-BNA
coc-A (13) this work 788 388 328
C30-endo
4-6) (A-form RNA) 838 38.68 38 08–368
Figure 4. (A) CD spectra of BNA
COC duplex 27/30 (red line), BNA
COC/RNA heteroduplexes 27/29 (orange line) and 26/30 (green line), DNA duplex
25/28 (black line), RNA duplex 26/29 (blue line); (B) CD spectra of duplexes the BNA
COC/DNA heteroduplexes 27/28 (red line) and 25/30 (green
line) and DNA/RNA duplexes 25/29 (black line) and 26/28 (blue line). The spectra were recorded in 10mM sodium phosphate buﬀer (pH 7.2)
containing 100mM NaCl at 128C. The concentration of each strand was 4mM.
Nucleic Acids Research,2009, Vol.37, No. 4 12373. Jepsen,J. S. and Wengel,J. (2004) LNA-antisense rivals siRNA for
gene silencing. Curr. Opin. Drug Discov. Dev., 7, 188–194.
4. Saenger,W. (1984) Principles of Nucleic Acid Structure,
Springer-Verlag, New York.
5. Altona,C. and Sundaralingam,M. (1972) Conformational analysis of
the sugar ring in nucleosides and nucleotides. A new description using
the concept of pseudorotation. J. Am. Chem. Soc., 94, 8205–8212.
6. Arnott,S., Hukins,D.W.L. and Dover,S.D. (1972) Optimised
parameters for RNA double-helices. Biochem. Biophys. Res.
Commun., 48, 1392–1399.
7. Imanishi,T. and Obika,S. (1999) Synthesis and properties of novel
conformationally restrained nucleoside analogs. J. Synth. Org.
Chem., 57, 969–980.
8. Imanishi,T. and Obika,S. (2002) BNAs: novel nucleic acid
analogs with a bridged sugar moiety. Chem. Commun., 1653–1659.
9. Obika,S., Nanbu,D., Hari,Y., Morio,K., In,Y., Ishida,T. and
Imanishi,T. (1997) Synthesis of 20-O,40-C-methyleneuridine and
-cytidine. Novel bicyclic nucleosides having a ﬁxed C30-endo sugar
puckering. Tetrahedron Lett., 38, 8735–8738.
10. Obika,S., Nanbu,D., Hari,Y., Andoh,J., Morio,K., Doi,T. and
Imanishi,T. (1998) Stability and structural features of the duplexes
containing nucleoside analogues with a ﬁxed N-type conformation,
20-O,40-C-methylene ribonucleosides. Tetrahedron Lett., 39,
5401–5404.
11. Obika,S., Sekiguchi,M., Somjing,R. and Imanishi,T. (2005)
Adjustment of the g dihedral angle of an oligonucleotide P30!N50
phosphoramidate enhances its binding aﬃnity towards
complementary strands. Angew. Chem. Int. Ed., 44, 1944–1947.
12. Sekiguch,M., Obika,S., Harada,Y., Osaki,T., Somjing,R.,
Mitsuoka,Y., Shibata,N., Masaki,M. and Imanishi,T. (2006)
Synthesis and properties of trans-30,40-bridged nucleic acids having
typical S-type sugar conformation. J. Org. Chem., 71, 1306–1316.
13. Osaki,T., Obika,S., Harada,Y., Mitsuoka,Y., Sugaya,K.,
Sekiguchi,M., Roongjang,S. and Imanishi,T. (2007) Development of
a novel nucleoside analogue with S-type sugar conformation:
20-deoxy-trans-30,40-bridged nucleic acids. Tetrahedron, 63,
8977–8986.
14. Kodama,T., Sugaya,K., Harada,Y., Mitsuoka,Y., Imanishi,T. and
Obika,S. (2009) Synthesis and properties of 20-deoxy-trans-30,40-
BNA with S-type sugar puckering. Heterocycles, 77, in press.
15. Kodama,T., Sugaya,K., Baba,T., Imanishi,T. and Obika,S. (2009)
Synthesis of a novel trans-30,40-BNA monomer bearing a 4,8-dioxa-
5-azabicyclo[5.3.0]decane skeleton. Heterocycles, 79, in press.
16. Miyashita,K., Rahman,S.M.A., Seki,S., Obika,S. and Imanishi,T.
(2007) N-Methyl substituted 20,40-BNA
NC: a highly nuclease-
resistance nucleic acid analogue with high-aﬃnity RNA selective
hybridization. Chem. Commun., 3765–3767.
17. Rahman,S.M.A., Seki,S., Utsuki,K., Obika,S., Miyashita,K. and
Imanishi,T. (2007) 20,40-BNA
NC: a novel bridged nucleic acid
analogue with excellent hybridizing and nuclease resistance proﬁles.
Nucleosides Nucleotides Nucleic Acids, 26, 1625–1628.
18. Rahman,S.M.A., Seki,S., Obika,S., Haitani,S., Miyashita,K. and
Imanishi,T. (2007) Highly stable pyrimidine-motif triplex formation
at physiological pH values by a bridged nucleic acid analogue.
Angew. Chem. Int. Ed., 46, 4306–4309.
19. Rahman,S.M.A., Seki,S., Obika,S., Yoshikawa,H., Miyashita,K.
and Imanishi,T. (2008) Design, synthesis, and properties of
20,40-BNA
NC: a bridged nucleic acid analogue. J. Am. Chem. Soc.,
130, 4886–4896.
20. Singh,S.K., Nielsen,P., Koshkin,A.A. and Wengel,J. (1998) LNA
(locked nucleic acids): synthesis and high-aﬃnity nucleic acid
recognition. Chem. Commun., 455–456.
21. Koshkin,A.A., Singh,S.K., Nielsen,P., Rajwanshi,V. K., Kumar,R.,
Meldgaard,M., Olsen,C.E. and Wengel,J. (1998) LNA (locked
nucleic acids): synthesis of the adenine, guanine, 5-methylcytosine,
thymine and uracil bicyclonucleoside monomers, oligomerisation,
and unprecedented nucleic acid recognition. Tetrahedron, 54,
3607–3630.
22. Jepsen,J.S. and Wengel,J. (2004) LNA (locked nucleic acid): high-
aﬃnity targeting of complementary RNA and DNA. Biochemistry,
43, 13233–13244.
23. Morita,K., Hasegawa,C., Kaneko,M., Tsutsumi,S., Sone,J.,
Ishikawa,T., Imanishi,T. and Koizumi,M. (2002) 20-O,40-C-ethylene-
bridged nucleic acids (ENA): highly nuclease-resistant and thermo-
dynamically stable oligonucleotides for antisense drug. Bioorg. Med.
Chem. Lett., 12, 73–76.
24. Morita,K., Takagi,M., Hasegawa,C., Kaneko,M., Tsutsumi,S.,
Sone,J., Ishikawa,T., Imanishi,T. and Koizumi,M. (2003) Synthesis
and properties of 20-O,40-C-ethylene-bridged nucleic acids (ENA) as
eﬀective antisense oligonucleotides. Bioorg. Med. Chem., 11,
2211–2226.
25. Wang,G., Gunic,E., Giratdet,J.-L. and Stoisavljevic,V. (1999)
Conformationally locked nucleosides. Synthesis and hybridization
properties of oligodeoxynucleotides containing 20,40-C-bridged
20-deoxynucleosides. Bioorg. Med. Chem. Lett., 9, 1147–1150.
26. Wang,G., Giratdet,J.-L. and Gunic,E. (1999) Conformationally
locked nucleosides. Synthesis and stereochemical assignments of
20,40-C-bridged bicyclonucleosides. Tetrahedron, 55, 7707–7724.
27. Freier,S.M. and Altmann,K.-H. (1997) The ups and downs of
nucleic acid duplex stability: structure–stability studies on chemi-
cally-modiﬁed DNA:RNA duplexes. Nucleic Acids Res., 25,
4429–4443.
28. Albæk,N., Petersen,M. and Nielsen,P. (2006) Analogues of a
locked nucleic acid with three-carbon 20,40-linkages: Synthesis
by ring-closing metathesis and inﬂuence on nucleic acid duplex
stability and structure. J. Org. Chem., 71, 7731–7740.
29. Srivastava,P., Barman,J., Pathmasiri,W., Plashkevych,O.,
Wenska,M. and Chattopadhyaya,J. (2007) Five- and six-membered
conformationally locked 20,40-carbocyclic ribo-thymidines: synthesis,
structure, and biochemical studies. J. Am. Chem. Soc., 129,
8362–8379.
30. Hari,Y., Obika,S., Ohnishi,R., Eguchi,K., Osaki,T., Ohishi,H. and
Imanishi,T. (2006) Synthesis and properties of 20-O,40-C-methyle-
neoxymethylene bridged nucleic acid. Bioorg. Med. Chem., 14,
1029–1038.
31. Zoltewicz,J.A., Clark,D.F., Sharpless,T.W. and Grahe,G. (1970)
Kinetics and mechanism of the acid catalyzed hydrolysis of some
purine nucleosides. J. Am. Chem. Soc., 92, 1741–1750.
32. Vorbru ¨ ggen,H., Krolikiewicz,K. and Bennua,B. (1981) Nucleoside
synthesis with trimethylsilyl triﬂate and perchlorate as catalysts.
Chem. Ber., 114, 1234–1255.
33. Vorbru ¨ ggen,H. and Ho ¨ ﬂe,G. (1981) On the mechanism of nucleo-
side synthesis. Chem. Ber., 114, 1256–1268.
34. Hanessian,S., Yang-Chung,G., Lavallee,P. and Pernet,A.G. (1972)
Chemistry of a-alkoxy sulfoxides. Formation of methylene acetals
from dimethyl sulfoxide and alcohols. J. Am. Chem. Soc., 94,
8929–8931.
35. Ta ¨ rkoy,M., Bolli,M. and Leumann,C. (1994) Synthesis, pairing
properties, and calorimetric determination of duplex and triplex
stability of decanucleotides from [(30S,50R)-20-deoxy-30,50-ethano-
 -D-ribofuranosyl]adenine and -thymine. Helv. Chim. Acta, 77,
716–744.
36. Robins,M.J., Zou,R., Guo,Z. and Wnuk,S.F. (1996) A solution for
the historic problem of regioselective sugar–base coupling to pro-
duce 9-glycosylguanines or 7-glycosylguanines. J. Org. Chem., 61,
9207–9212.
37. Ackermann,D. and Pitsch,S. (2002) Synthesis and pairing properties
of 30-deoxyribopyranose (40!20)-oligonucleotides (‘p-DNA’). Helv.
Chim. Acta, 85, 1443–1462.
38. Nielsen,KE., Rasmussen,J., Kumar,R., Wengel,J., Jacobsen,J.P. and
Petersen,M. (2004) NMR studies of fully modiﬁed locked nucleic
acid (LNA) hybrids: Solution structure of an LNA:RNA hybrid
and characterization of an LNA:DNA hybrid. Bioconjugate Chem.,
15, 449–457.
39. Pande,V. and Nilsson,L. (2008) Insights into structure, dynamics and
hydration of locked nucleic acid (LNA) strand-based duplexes from
molecular dynamics simulations. Nucleic Acids Res., 36, 1508–1516.
40. Plashkevych,O., Chatterjee,S., Honcharenko,D., Pathmasiri,W. and
Chattopadhyaya,J. (2007) Chemical and structural implications
of 10,20- versus 20,40-conformational constraints in the sugar
moiety of modiﬁed thymine nucleosides. J. Org. Chem., 72,
4716–4726.
1238 Nucleic Acids Research, 2009, Vol. 37,No. 4